PWAC
CRDF icon

Private Wealth Advisors (California)’s Cardiff Oncology CRDF Stock Holding History

Private Wealth Advisors (California)’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,959
Closed -$315K – 95
2020
Q4 		$315K Sell
17,959
-435
-2% -$7.64K 0.11% 59
2020
Q3 		$261K Buy
+18,394
New +$121K 0.14% 52

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Private Wealth Advisors (California)'s CRDF Position: Q1 2021 in Review

Private Wealth Advisors (California) sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 17,959 shares — an estimated $315K sold.

Private Wealth Advisors (California) first reported a position in CRDF in Q3 2020 and held it in 2 quarters. The position peaked at $315K in Q4 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • Private Wealth Advisors (California) reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • Private Wealth Advisors (California) sold 17,959 Cardiff Oncology shares in Q1 2021, an estimated $315K.
  • Private Wealth Advisors (California) first reported a position in Cardiff Oncology in Q3 2020 and held it in 2 quarters.
  • Private Wealth Advisors (California)'s Cardiff Oncology position peaked at $315K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Private Wealth Advisors (California)'s 13F filing for Q1 2021, filed 17 May 2021.